Tower Research Capital LLC (TRC)
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1533421
NEW YORK, NY
Position in INDV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$288,522
+$258,195 QoQ
Shares Held
7,032
+606.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#228
of 334 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INDV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $14,082,412 across 58 Drug Manufacturers - Specialty & Generic names. INDV ranks #8 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
111,351 | $3,860,538 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
3,880 | $2,102,300 | |
| 3 | ZTS |
Zoetis Inc.
|
24,069 | $1,729,598 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
7,270 | $1,225,285 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
38,301 | $942,587 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
6,773 | $751,395 | |
| 7 | ALKS |
Alkermes plc.
|
6,157 | $322,626 | |
| 8 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
7,032 | $288,522 |
All Filings in INDV
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $288,522 | 7,032 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $30,327 | 995 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||